Theresa Swift-Scanlan, Ph.D. - Publications

2007 Johns Hopkins University, Baltimore, MD 
Genetics, Oncology

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Conway K, Edmiston SN, Parrish E, Bryant C, Tse CK, Swift-Scanlan T, McCullough LE, Kuan PF. Breast tumor DNA methylation patterns associated with smoking in the Carolina Breast Cancer Study. Breast Cancer Research and Treatment. PMID 28275920 DOI: 10.1007/S10549-017-4178-8  0.42
2016 Garcia-Bloj B, Moses C, Sgro A, Plani-Lam J, Arooj M, Duffy C, Thiruvengadam S, Sorolla A, Rashwan R, Mancera RL, Leisewitz A, Swift-Scanlan T, Corvalan AH, Blancafort P. Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system. Oncotarget. PMID 27528034 DOI: 10.18632/Oncotarget.11142  0.36
2015 Conway K, Edmiston SN, Tse CK, Bryant C, Kuan PF, Hair BY, Parrish EA, May R, Swift-Scanlan T. Racial variation in breast tumor promoter methylation in the Carolina breast cancer study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 921-30. PMID 25809865 DOI: 10.1158/1055-9965.Epi-14-1228  0.477
2015 Stolzenburg S, Beltran AS, Swift-Scanlan T, Rivenbark AG, Rashwan R, Blancafort P. Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer. Oncogene. PMID 25684141 DOI: 10.1038/Onc.2014.470  0.427
2015 Hair BY, Troester MA, Edmiston SN, Parrish EA, Robinson WR, Wu MC, Olshan AF, Swift-Scanlan T, Conway K. Body mass index is associated with gene methylation in estrogen receptor-positive breast tumors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 580-6. PMID 25583948 DOI: 10.1158/1055-9965.Epi-14-1017  0.438
2014 Rattani NS, Swift-Scanlan T. Deconstructing breast cancer heterogeneity: clinical implications for women with Basal-like tumors. Oncology Nursing Forum. 41: 639-46. PMID 25355019 DOI: 10.1188/14.Onf.639-646  0.39
2014 Conway K, Edmiston SN, May R, Kuan PF, Chu H, Bryant C, Tse CK, Swift-Scanlan T, Geradts J, Troester MA, Millikan RC. DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival. Breast Cancer Research : Bcr. 16: 450. PMID 25287138 DOI: 10.1186/S13058-014-0450-6  0.45
2014 Swift-Scanlan T, Smith CT, Bardowell SA, Boettiger CA. Comprehensive interrogation of CpG island methylation in the gene encoding COMT, a key estrogen and catecholamine regulator. Bmc Medical Genomics. 7: 5. PMID 24460628 DOI: 10.1186/1755-8794-7-5  0.368
2013 Bardowell SA, Parker J, Fan C, Crandell J, Perou CM, Swift-Scanlan T. Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns. Breast Cancer Research and Treatment. 142: 365-80. PMID 24212716 DOI: 10.1007/S10549-013-2738-0  0.454
2013 Ulirsch J, Fan C, Knafl G, Wu MJ, Coleman B, Perou CM, Swift-Scanlan T. Vimentin DNA methylation predicts survival in breast cancer. Breast Cancer Research and Treatment. 137: 383-96. PMID 23239149 DOI: 10.1007/S10549-012-2353-5  0.466
2011 Swift-Scanlan T, Vang R, Blackford A, Fackler MJ, Sukumar S. Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort. Cancer Biology & Therapy. 11: 853-65. PMID 21383541 DOI: 10.4161/Cbt.11.10.15177  0.472
2009 Troester MA, Swift-Scanlan T. Challenges in studying the etiology of breast cancer subtypes. Breast Cancer Research : Bcr. 11: 104. PMID 19635173 DOI: 10.1186/Bcr2323  0.419
2006 Fackler MJ, Malone K, Zhang Z, Schilling E, Garrett-Mayer E, Swift-Scanlan T, Lange J, Nayar R, Davidson NE, Khan SA, Sukumar S. Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3306-10. PMID 16740751 DOI: 10.1158/1078-0432.Ccr-05-2733  0.44
2006 Swift-Scanlan T, Blackford A, Argani P, Sukumar S, Fackler MJ. Two-color quantitative multiplex methylation-specific PCR. Biotechniques. 40: 210-9. PMID 16526411 DOI: 10.2144/000112097  0.324
Show low-probability matches.